The memory ameliorating effects of INM-176, an ethanolic extract of Angelica gigas, against scopolamine- or Aβ1-42-induced cognitive dysfunction in mice

Journal of Ethnopharmacology

Volumn 143, Issue 2, 2012, Pages 611-620

  Park, Se Jin ^a,b   Jung, Jun Man ^a,b   Lee, Hyung Eun ^a,b   Lee, Young Woo ^a,b   Kim, Dong Hyun ^a,b   Kim, Jong Min ^a,b   Hong, Jin Gyu ^a,b   Lee, Chang Hwan ^a,b   Jung, In Ho ^c   Cho, Yong Baik ^c   Jang, Dae Sik ^a,b   Ryu, Jong Hoon ^a,b  

^a Department of Life and Nanopharmaceutical Science ^*  (South Korea)

^b Kyung Hee University   (South Korea)

^c WhanIn Pharmaceutical Co Ltd   (South Korea)

Author keywords

Acetylcholinesterase; Amyloid protein; Angelica gigas; INM 176; Memory; Neuroprotection

Indexed keywords

ACETYLCHOLINESTERASE; AMYLOID BETA PROTEIN[1-42]; ANGELICA GIGAS EXTRACT; CHLOROGENIC ACID; DECURSIN; DECURSINOL; DECURSINOL ANGELATE; DONEPEZIL; FERULIC ACID; INM 176; NEUROPROTECTIVE AGENT; NODAKENIN; SCOPOLAMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; ASTROCYTOSIS; CELL ACTIVATION; CELL DAMAGE; CELL LOSS; COGNITIVE DEFECT; ENZYME ACTIVITY; ENZYME INHIBITION; HIPPOCAMPAL CA3 REGION; HIPPOCAMPUS; LONG TERM CARE; MALE; MAZE TEST; MEMORY DISORDER; MEYNERT BASAL NUCLEUS; MOUSE; NERVE CELL; NEUROPROTECTION; NONHUMAN; PASSIVE AVOIDANCE; SINGLE DRUG DOSE;

ACETYLCHOLINESTERASE; AMYLOID BETA-PEPTIDES; ANGELICA; ANIMALS; ASTROCYTES; AVOIDANCE LEARNING; CHOLINESTERASE INHIBITORS; COGNITION DISORDERS; ETHANOL; HIPPOCAMPUS; MALE; MAZE LEARNING; MEMORY; MEMORY DISORDERS; MICE; MICE, INBRED ICR; NEUROPROTECTIVE AGENTS; PEPTIDE FRAGMENTS; PHYTOTHERAPY; PLANT EXTRACTS; SCOPOLAMINE HYDROBROMIDE; SOLVENTS;

ANGELICA GIGAS; MUS;

EID: 84866005647     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2012.07.019     Document Type: Article

References (39)

1. J.Y. Cho, H.S. Kim, D.H. Kim, J.J. Yan, H.W. Suh, and D.K. Song Inhibitory effects of long-term administration of ferulic acid on astrocyte activation induced by intracerebroventricular injection of β-amyloid peptide (1-42) in mice Progress in Neuro-Psychopharmacology & Biological Psychiatry 29 2005 901 907
2. K. Chopra, S. Misra, and A. Kuhad Neurobiological aspects of Alzheimer's disease Expert Opinion on Therapeutic Targets 15 2011 535 555
3. C.W. Cotman, A.J. Tenner, and B.J. Cummings β-Amyloid converts an acute phase injury response to chronic injury responses Neurobiology of Aging 17 1996 723 731
4. J.L. Cummings, J. Mackell, and D. Kaufer Behavioral effects of current Alzheimer's disease treatments: a descriptive review Alzheimer's & Dementia 4 2008 49 60
5. G.L. Ellman, K.D. Courtney, V. Andres Jr.; and R.M. Feather-Stone A new and rapid colorimetric determination of acetylcholinesterase activity Biochemical Pharmacology 7 1961 88 95
6. L. Giovannelli, F. Casamenti, C. Scali, L. Bartolini, and G. Pepeu Differential effects of amyloid peptides β-(1-40) and β-(25-35) injections into the rat nucleus basalis Neuroscience 66 1995 781 792
7. I. Granic, C. Nyakas, P.G. Luiten, U.L. Eisel, L.G. Halmy, G. Gross, H. Schoemaker, A. Moller, and V. Nimmrich Calpain inhibition prevents amyloid-β-induced neurodegeneration and associated behavioral dysfunction in rats Neuropharmacology 59 2010 334 342
8. J. Hardy, and D.J. Selkoe The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 297 2002 353 356
9. J.A. Hardy, and G.A. Higgins Alzheimer's disease: the amyloid cascade hypothesis Science 256 1992 184 185
10. M.T. Heneka, M.K. O'Banion, D. Terwel, and M.P. Kummer Neuroinflammatory processes in Alzheimer's disease Journal of Neural Transmission 117 2010 919 947
11. 1-42 suppresses acetylcholine synthesis. Possible role in cholinergic dysfunction in Alzheimer's disease The Journal of Biological Chemistry 272 1997 2038 2041
12. M.D. Ikonomovic, E.J. Mufson, J. Wuu, E.J. Cochran, D.A. Bennett, and S.T. DeKosky Cholinergic plasticity in hippocampus of individuals with mild cognitive impairment: correlation with Alzheimer's neuropathology Journal of Alzheimer's Disease 5 2003 39 48
13. S.Y. Kang, K.Y. Lee, K.A. Koo, J.S. Yoon, S.W. Lim, Y.C. Kim, and S.H. Sung ESP-102, a standardized combined extract of Angelica gigas, Saururus chinensis and Schizandra chinensis, significantly improved scopolamine-induced memory impairment in mice Life Sciences 76 2005 1691 1705
14. S.Y. Kang, K.Y. Lee, M.J. Park, Y.C. Kim, G.J. Markelonis, and T.H. Oh Decursin from Angelica gigas mitigates amnesia induced by scopolamine in mice Neurobiology of Learning and Memory 79 2003 11 18
15. S.Y. Kang, K.Y. Lee, S.H. Sung, M.J. Park, and Y.C. Kim Coumarins isolated from Angelica gigas inhibit acetylcholinesterase: structure-activity relationships Journal of Natural Products 64 2001 683 685
16. E. Karran, M. Mercken, and B. De Strooper The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics Nature Reviews Drug Discovery 10 2011 698 712
17. 1-42-induced memory impairment in mice Pharmacology Biochemistry and Behavior 97 2010 239 248
18. D.H. Kim, Y. Kim do, Y.C. Kim, J.W. Jung, S. Lee, B.H. Yoon, J.H. Cheong, Y.S. Kim, S.S. Kang, K.H. Ko, and J.H. Ryu Nodakenin, a coumarin compound, ameliorates scopolamine-induced memory disruption in mice Life Sciences 80 2007 1944 1950
19. J.H. Kim, S.K. Koh, H.J. Koh, Y.A. Kwon, S.H. Kim, J.G. Kim, T.E. Kim, J.W. Park, M.Y. Seo, Y.R. Song, I. Lee, and D.K. Kim A three month placebo-controlled clinical trial of INM 176 in the old aged subjects with memory impairment Journal of Korean Neuropsychiatric Association 42 2003 254 262
20. D.L. King, and G.W. Arendash Behavioral characterization of the Tg2576 transgenic model of Alzheimer's disease through 19 months Physiology & Behavior 75 2002 627 642
21. S.H. Kwon, H.K. Lee, J.A. Kim, S.I. Hong, H.C. Kim, T.H. Jo, Y.I. Park, C.K. Lee, Y.B. Kim, S.Y. Lee, and C.G. Jang Neuroprotective effects of chlorogenic acid on scopolamine-induced amnesia via anti-acetylcholinesterase and anti-oxidative activities in mice European Journal of Pharmacology 649 2010 210 217
22. C. Li, R. Zhao, K. Gao, Z. Wei, M.Y. Yin, L.T. Lau, D. Chui, and Yu, A.C. Hoi Astrocytes: implications for neuroinflammatory pathogenesis of Alzheimer's disease Current Alzheimer Research 8 2011 67 80
23. R.B. Maccioni, L.E. Rojo, J.A. Fernandez, and R.O. Kuljis The role of neuroimmunomodulation in Alzheimer's disease Annals of the New York Academy of Sciences 1153 2009 240 246
24. E.J. Mufson, S.E. Counts, S.E. Perez, and S.D. Ginsberg Cholinergic system during the progression of Alzheimer's disease: therapeutic implications Expert Review of Neurotherapeutics 8 2008 1703 1718
25. M. Pakaski, and J. Kalman Interactions between the amyloid and cholinergic mechanisms in Alzheimer's disease Neurochemistry International 53 2008 103 111
26. H.S. Park, B. Kim, J.H. Oh, Y.C. Kim, and Y.J. Lee First-pass metabolism of decursin, a bioactive compound of Angelica gigas, in rats Planta Medica 78 2012 909 913
27. S.J. Park, H.J. Jung, M.S. Son, J.M. Jung, D.H. Kim, I.H. Jung, Y.B. Cho, E.H. Lee, and J.H. Ryu Neuroprotective effects of INM-176 against lipopolysaccharide-induced neuronal injury Pharmacology Biochemistry and Behavior 101 2012 427 433
28. S.J. Park, D.H. Kim, I.K. Lee, W.Y. Jung, D.H. Park, J.M. Kim, K.R. Lee, K.T. Lee, C.Y. Shin, J.H. Cheong, K.H. Ko, and J.H. Ryu The ameliorating effect of the extract of the flower of Prunella vulgaris var. lilacina on drug-induced memory impairments in mice Food and Chemical Toxicology 48 2010 1671 1676
29. G. Paxinos, and K.B.J. Franklin The Mouse Brain in Stereotaxic Coordinates 2001 Academic Press San Diego
30. S. Reagan-Shaw, M. Nihal, and N. Ahmad Dose translation from animal to human studies revisited FASEB Journal 22 2008 659 661
31. J.J. Rodriguez, M. Olabarria, A. Chvatal, and A. Verkhratsky Astroglia in dementia and Alzheimer's disease Cell Death & Differentiation 16 2009 378 385
32. S.D. Sarker, and L. Nahar Natural medicine: the genus Angelica Current Medicinal Chemistry 11 2004 1479 1500
33. V. Scheid Chinese Herbal Medicine: Formulas & Strategies 2009 Eastland Press Seattle, WA
34. R.D. Terry, E. Masliah, D.P. Salmon, N. Butters, R. DeTeresa, R. Hill, L.A. Hansen, and R. Katzman Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment Annals of Neurology 30 1991 572 580
35. E.A. van der Zee, and P.G. Luiten Muscarinic acetylcholine receptors in the hippocampus, neocortex and amygdala: a review of immunocytochemical localization in relation to learning and memory Progress in Neurobiology 58 1999 409 471
36. G.L. Wenk, K. McGann-Gramling, B. Hauss-Wegrzyniak, D. Ronchetti, R. Maucci, S. Rosi, L. Gasparini, and E. Ongini Attenuation of chronic neuroinflammation by a nitric oxide-releasing derivative of the antioxidant ferulic acid Journal of Neurochemistry 89 2004 484 493
37. J.J. Yan, J.Y. Cho, H.S. Kim, K.L. Kim, J.S. Jung, S.O. Huh, H.W. Suh, Y.H. Kim, and D.K. Song Protection against β-amyloid peptide toxicity in vivo with long-term administration of ferulic acid British Journal of Pharmacology 133 2001 89 96
38. J.J. Yan, D.H. Kim, Y.S. Moon, J.S. Jung, E.M. Ahn, N.I. Baek, and D.K. Song Protection against β-amyloid peptide-induced memory impairment with long-term administration of extract of Angelica gigas or decursinol in mice Progress in Neuro-Psychopharmacology & Biological Psychiatry 28 2004 25 30
39. Y.-P. Zhu Chinese Materia Medica: Chemistry, Pharmacology, and Applications 1998 Harwood Academic, Amsterdam The Netherlands